0001493152-21-022863.txt : 20210915 0001493152-21-022863.hdr.sgml : 20210915 20210915215017 ACCESSION NUMBER: 0001493152-21-022863 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210913 FILED AS OF DATE: 20210915 DATE AS OF CHANGE: 20210915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jenusaitis Matthew CENTRAL INDEX KEY: 0001357864 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38325 FILM NUMBER: 211256846 MAIL ADDRESS: STREET 1: 2 GOODYEAR CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hancock Jaffe Laboratories, Inc. CENTRAL INDEX KEY: 0001661053 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330936180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-261-2900 MAIL ADDRESS: STREET 1: 70 DOPPLER CITY: IRVINE STATE: CA ZIP: 92618 4 1 ownership.xml X0306 4 2021-09-13 0 0001661053 Hancock Jaffe Laboratories, Inc. HIJI 0001357864 Jenusaitis Matthew 70 DOPPLER IRVINE CA 92618 1 0 0 0 Common Stock 2021-09-13 4 M 0 1042 A 5884 D Restricted Stock Units 2021-09-13 4 M 0 1042 0 D Common Stock 1042 2084 D Each restricted stock unit ("RSU") converts into one share of common stock of Hancock Jaffe Laboratories, Inc. On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021 /s/ Matthew Jenusaitis 2021-09-15